Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
Clinical trial NCT00732498 · COMPLETED
Trial details
- NCT number
- NCT00732498
- Sponsor
- University of Arizona
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-15
- Primary completion
- 2018-10-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.